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836Objective:We sought to evaluate the impact of early surgery in the active phase on long-term outcomes in pa-
tients with left-sided native valve infective endocarditis.
Methods: Clinical data were retrospectively reviewed in 212 consecutive patients with left-sided native valve
infective endocarditis from 1990 to 2009. Early surgery in the active phase (within 2 weeks after the initial di-
agnosis) was performed in 73 patients, and the conventional treatment strategywas applied in 139 patients. In the
conventional treatment group, 99 patients underwent late surgical intervention. To minimize selection bias, pro-
pensity scorewas used to match patients in the early operation and conventional treatment groups.Major adverse
cardiac event was defined as a composite of infective endocarditis-related death, repeat surgery, and recurrence
of infective endocarditis during follow-up.
Results: The mean follow-up period was 5.5 years. In-hospital mortality was lower in the early operation group
than in the conventional treatment group (5% vs 13%, P ¼ .08). For 57 propensity score-matched pairs, the
estimated actuarial 7-year survivals free from infective endocarditis-related death and major adverse cardiac
events were significantly higher in the early operation group than in the conventional treatment group (infective
endocarditis-related death: 94%  5% vs 82%  5%, P ¼ .011, major adverse cardiac events: 88%  5% vs
69%  7%, P ¼ .006, respectively).
Conclusions: Compared with conventional treatment, early surgery in the active phase was associated with bet-
ter long-term outcomes in patients with left-sided native valve infective endocarditis. Further prospective ran-
domized studies with large study populations are necessary to evaluate more precisely the optimal timing of
surgery in patients with native valve infective endocarditis. (J Thorac Cardiovasc Surg 2011;142:836-42)Supplemental material is available online.
The optimal timing of surgical intervention in patients with
left-sided native valve infective endocarditis (IE) has not
been clarified, and considerable controversy remains re-
garding the role of early surgery. Early surgical intervention
in the acute or active phase of IE in the presence of uncon-
trolled sepsis, shock, and organ failure raises concerns
about high operative mortality and risk of relapsing IE.
On the other hand, postponing surgery to complete a course
of antimicrobial therapy could increase embolic risk and
cause extensive cardiac tissue damage, which result in
more difficult repair, progressive cardiogenic shock and
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The Journal of Thoracic and Cardiovascular SurgRecent studies have investigated the impact of surgical
intervention for left-sided IE and suggested benefits of
valve surgery.1-6 However, these studies were limited by
a short follow-up. Moreover, improved long-term outcomes
by early surgery for left-sided IE have not been clearly
shown because of the lack of controlled trials and the inher-
ent biases of observational studies. The present study
compared the long-term clinical outcomes of patients with
left-sided native valve IE who underwent early surgery in
the active phase with patients who received the conven-
tional treatment strategy. We tried to minimize the inherent
biases in treatment selection and prognostic imbalances
using propensity analyses and multivariable modeling.MATERIALS AND METHODS
Study Population
From 1990 to 2009, 212 patients with active left-sided native valve IE
who were admitted to the Kobe City Medical Center General Hospital
were enrolled. All patients met the modified Duke criteria for definite or
possible endocarditis. For patients with multiple episodes of endocarditis,
the first episode was considered as the index episode.
Clinical Data
Clinical data were retrospectively reviewed in 212 consecutive patients
with IE. From medical records, we extracted data on sociodemographics,
comorbid conditions, previous heart disease, microorganisms isolated,ery c October 2011
Abbreviations and Acronyms
IE ¼ infective endocarditis
MACE ¼ major adverse cardiac event
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Dechocardiographic findings, occurrence of IE complications, timing and
type of cardiac surgery, euroSCORE, and outcomes. We evaluated both
the additive and logistic euroSCOREs to assess the operative risk at the
time of admission.
In the present study, the median time between IE diagnosis and surgery
was 8 days in patients who underwent operation during the initial antibiotic
therapy (n ¼ 100). Of these, 50 patients underwent surgery within 7 days
and 23 patients underwent surgery within 8 to 14 days after the initial di-
agnosis. As a result, approximately 75% of the patients underwent opera-
tion within 14 days. During the 14-day period after the initial diagnosis, the
risk of embolism has been reported to be higher than after 14 days.7,8 We
think that surgery within this period could be a reasonable therapeutic
option with the purpose of avoiding new embolic events. Thus, we
defined early operation as surgical intervention within 2 weeks and late
operation as surgical intervention more than 2 weeks after the initial
diagnosis of IE. The indications for valve surgery in this study
population were as follows: heart failure unresponsive to medical
therapy, persistent infection, repeat embolization, high embolic risk, and
presence of perivalvular extension of IE. In addition, the late operation
was indicated in patients undergoing conventional treatment because of
residual severe regurgitation after the resolution of infection. Repeat
surgery was defined as the second cardiac surgery excluding the first
surgical intervention for IE.
Outcomes
The end points of this study were IE-related death and major adverse
cardiac event (MACE). MACE was defined as a composite of IE-related
death, repeat surgery, and recurrence of IE during follow-up. Long-term
outcome was determined through examination of medical records. IE-
related death included cardiac death and death caused by the complications
of IE, while excluding death obviously unrelated to IE, for example, death
due to malignant disease and traffic accident.Statistical Analysis
Differences between patients undergoing the early operation and pa-
tients receiving conventional treatment were compared using the chi-
square test or Fisher exact test for categoric variables. Continuous variables
are described as mean  standard deviation, except for operative days and
survivals (mean standard error), and compared with unpaired t tests. Be-
cause operative days after the onset were not normally distributed, the
Mann–Whitney U test was performed to assess differences. Survival anal-
ysis was performed by Kaplan–Meier analysis, and differences in survival
between groups were examined with the log-rank test.
To reduce selection bias, we performed rigorous adjustment for differ-
ences in the baseline characteristics by use of propensity score matching.
By using multivariable logistic regression, a propensity score model was
created to estimate the likelihood of early operation. A nearest-neighbor
matching algorithm was used to match patients on the logit of the propen-
sity scorewith a caliper width of 0.2 of the standard deviation of the logit of
the propensity score. After propensity score matching, the baseline covari-
ates were compared between the 2 groups with the paired t test orWilcoxon
signed-rank test for continuous variables and the McNemar test for cate-
goric variables. Survival curves were constructed with Kaplan–Meier esti-
mates and compared with the log-rank test. For Kaplan–Meier analysis, we
analyzed all clinical events by time to first event. Data analysis was per-
formed with SPSS software (Version 17.0; SPSS, Inc, Chicago, IL).The Journal of Thoracic and CaRESULTS
Patient Characteristics
Of the 212 patients, 73 underwent early operation and
139 received the conventional treatment. In the conven-
tional treatment group, 99 patients underwent late surgical
intervention and 40 patients received medical treatment
alone. The baseline characteristics of the early operation
group compared with the conventional treatment group
are summarized in Table 1. Patients in the early operation
group were more likely to have aortic valve involvement,
heart failure, valve perforation, and large vegetations. The
euroSCORE was higher in the early operation group than
in the conventional treatment group. There were no signif-
icant differences in terms of causative microorganism and
cerebrovascular complications between the 2 groups, and
the most common causative microorganism in both groups
was Streptococcus species.Surgical Interventions
Surgery was performed at a median of 5 days after the ini-
tial diagnosis of IE in the early operation group and at a me-
dian of 45 days in the conventional treatment group. In the
early operation group (n ¼ 73), 53 patients had mitral valve
endocarditis. Of the 53 patients, mitral valve repair was per-
formed in40 (75%). Inpatientswhounderwent lateoperation
in the conventional treatment group (n ¼ 99), 69 had mitral
valve endocarditis and mitral valve repair was performed in
54 (78%).When the infection involved the aorticvalve, aortic
valve replacementwas performed in 95% of all patients. Car-
diopulmonary bypass time and aorta clamp timewere signif-
icantly longer in the early operation group, whereas the
operative complications were comparable between the 2
groups. Table 2 summarizes the surgical procedures.Clinical Outcomes
The in-hospital mortality was lower in the early operation
group (5% vs 13%, P¼ .08), whereas the operative mortal-
ity was comparable between the early operation group and
the late operation group (5% vs 5%, P ¼ .58).
In the conventional treatment group, 4 patients had new
cerebral infarction or cerebral hemorrhage and 6 patients
died during the initial hospitalization as the result of wors-
ening heart failure and sepsis more than 2 weeks after the
initial diagnosis of IE.
The mean follow-up period was 5.5  5.1 years. There
were 6 IE-related deaths and 7 non–IE-related deaths in
the early operation group during follow-up, whereas there
were 19 IE-related deaths and 6 non–IE-related deaths in
the conventional treatment group. In addition, there were
8 repeat operations, 6 recurrences of IE, and no admission
for heart failure in the early operation group, compared
with 10 repeat operations, 5 recurrences of IE, and 6 admis-
sions for heart failure in the conventional treatment group.rdiovascular Surgery c Volume 142, Number 4 837
TABLE 1. Baseline characteristics before propensity matching
Early
operation
(n ¼ 73)
Conventional
treatment
(n ¼ 139)
P
value
Background
Age, y  SD 55  18 53  17 .46
Male, n (%) 44 (60) 85 (61) .90
Date of initial diagnosis
(year 2000–2009), n (%)
48 (66) 80 (58) .25
Hypertension, n (%) 14 (19) 34 (24) .38
Diabetes, n (%) 13 (18) 22 (16) .71
Chronic renal failure, n (%) 13 (18) 15 (11) .15
Hemodialysis, n (%) 3 (4) 10 (7) .29
Valvular disease, n (%) 24 (33) 65 (47) .05
Coronary artery disease, n (%) 2 (3) 4 (3) .66
Ejection fraction<50%, n (%) 6 (8) 7 (5) .26
Pathogens
Blood culture positive, n (%) 55 (75) 104 (75) .93
Streptococcus sp, n (%) 33 (45) 70 (50) .48
Staphylococcus sp, n (%) 15 (21) 24 (17) .56
Vegetation site
Aortic valve, n (%) 38 (52) 47 (34) .01
Mitral valve, n (%) 53 (73) 103 (74) .81
Both aortic and mitral valves,
n (%)
18 (25) 19 (14) .05
Complication
Heart failure, n (%) 43 (59) 52 (37) .003
Valve perforation, n (%) 37 (51) 47 (34) .02
Cardiac abscess, n (%) 13 (18) 15 (11) .15
Vegetation size>10 mm,
n (%)
47 (64) 52 (37) <.001
Cerebral infarction, n (%) 29 (40) 41 (30) .13
Cerebral hemorrhage, n (%) 6 (8) 18 (13) .30
Mycotic aneurysm, n (%) 1 (1) 6 (4) .24
euroSCORE additive,
points  SD
6.6  3.0 4.4  3.6 <.001
euroSCORE logistic,%  SD 11.1  11 6.6  9.0 .001
SD, Standard deviation.
TABLE 2. Comparison of the surgical procedures between early
operation and late operation
Early
operation
(n ¼ 73)
Late
operation
(n ¼ 99)
P
value
Operative timing* 5 (3–9) 45 (27–78) <.001
Type of operation
Mitral valve repair, n (%) 29 (40) 45 (45) .45
Mitral valve replacement, n (%) 6 (8) 9 (9) .84
Aortic valve replacement, n (%) 20 (27) 23 (23) .53
Mitral valve repair and aortic valve
repair, n (%)
2 (3) 2 (2) .57
Mitral valve repair and aortic valve
replacement, n (%)
9 (12) 7 (7) .24
Mitral valve replacement and aortic
valve replacement, n (%)
7 (10) 6 (6) .39
Others, n (%) 0 (0) 7 (7) .02
Cardiopulmonary bypass time,
min  SD
181  60 151  54 .001
Aortic crossclamp time, min  SD 132  46 106  40 <.001
Root replacement, n (%) 5 (7) 1 (1) .05
Mechanical valve implantation,
n (%)
19 (28) 22 (23) .50
Postoperative morbidity
Bleeding, n (%) 5 (7) 2 (2) .12
Acute renal failure, n (%) 4 (6) 1 (1) .10
Respiratory failure, n (%) 4 (6) 1 (1) .10
Massive pericardial effusion, n (%) 1 (1) 2 (2) .61
Arrhythmia, n (%) 2 (3) 0 (0) .18
Hemolysis, n (%) 1 (1) 4 (4) .29
In-hospital death, n (%) 4 (5) 5 (5) .58
Reoperation during follow-up, n (%) 8 (11) 10 (10) .86
IE-related death during follow-up,
n (%)
6 (8) 6 (6) .58
SD, Standard deviation; IE, infective endocarditis. *Days after onset, median
(25th–75th percentile).
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87%, 85%, and 79%, respectively.
Propensity Score Matching
The propensity model included age, sex, hypertension,
diabetes, renal failure, coronary artery disease, ejection
fraction, heart valve disease, heart failure, valve involved,
valve perforation, intracardiac abscess, microbial cause,
vegetation size, cerebral infarction, cerebral hemorrhage,
and euroSCORE. One-to-one matching was performed,
and 114 patients were enrolled in the propensity-matched
group. In contrast with all the patients (n ¼ 212), the
2 propensity-matched groups revealed no significant differ-
ences in baseline variables (Table E1).
Early Operation and Long-Term Prognosis
In the propensity-matched patients (n ¼ 114), signifi-
cantly fewer IE-related deaths occurred in the early838 The Journal of Thoracic and Cardiovascular Surgoperation group (2 patients, 4%) than in the conventional
treatment group (11 patients, 19%; P ¼ .012) during
follow-up (Table 3). As a result, the estimated actuarial
7-year survivals free from IE-related death were 94% 
5% in the early operation group versus 82%  5% in the
conventional treatment group (P ¼ .011, Figure 1), and
the 7-year survivals free from MACE were 88%  5% in
the early operation group versus 69% 7% in the conven-
tional treatment group (P ¼ .006, Figure 2). The number of
reoperations as well as recurrences of IE was comparable
between the 2 groups (Table 3).Cerebral Complications and Neurologic Outcomes
Of all the study patients, 73 had complicating stroke on
admission. Diagnosis of stroke was made by computed to-
mography or magnetic resonance imaging. Table 4 shows
the comparison of cerebral complications and neurologic
outcomes between the early operation group and the con-
ventional treatment group. Patients in the early operationery c October 2011
TABLE 3. Comparison of clinical outcomes between early operation
and conventional treatment groups in propensity-matched pairs
Early
operation
(n ¼ 57)
Conventional
treatment
(n ¼ 57)
P
value
In-hospital death, n (%) 1 (2) 10 (18) .012
All cause death, n (%) 9 (16) 12 (21) .61
IE-related death, n (%) 2 (4) 11 (19) .012
Reoperation, n (%) 5 (9) 7 (12) .75
Recurrence IE, n (%) 3 (5) 3 (5) 1.00
Admission for heart failure, n (%) 0 (0) 3 (5) .25
IE, Infective endocarditis.
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and patients in the conventional treatment group were
more likely to have cerebral hemorrhage. The in-hospital
mortality was significantly lower in the early operation
group (3% vs 26%, P ¼ .01). In terms of neurologic out-
comes, the rate of neurologic worsening was comparable
between the 2 groups (13% vs 14%, P ¼ .61). In the early
operation group, 4 patients, including 3 with silent cerebral
infarction, had postoperative neurologic worsening due to
postoperative new cerebral infarction.DISCUSSION
This study evaluated the impact of early operation in ac-
tive phase on long-term outcomes in patients with left-sided
native valve IE. Compared with conventional treatment,
early surgery within 2 weeks after the initial diagnosis of
IE was associated with better long-term outcomes. There-
fore, our analysis suggests that early surgical intervention
within 2 weeks may further improve clinical outcomes in
patients with active left-sided native valve IE rather than
conventional medical treatment.FIGURE 1. Comparison of freedom rates from IE-related death between earl
pairs. Green line shows the survival curve in early operation group, and red lin
presented as the mean value  standard error. IE, Infective endocarditis.
The Journal of Thoracic and CaOne of the most difficult decisions in the treatment of IE
is whether to recommend valve surgery in patients with
active left-sided IE. Several observational studies have sug-
gested a benefit of surgical intervention compared with con-
ventional medical therapy alone.2-5 Vikram and colleagues6
evaluated the impact of valve surgery on 6-month mortality
in left-sided IE using a propensity score analysis and
concluded that valve surgery for patients with complicated
IE was independently associated with reduced 6-month
mortality. Conversely, Tleyjeh and colleagues9 suggested
that valve surgery in left-sided IE did not provide a survival
benefit but was rather associated with increased 6-month
mortality. Because they did not analyze the association of
timing of surgery on clinical outcome, this discrepancy
might arise from a difference in operative timing. Optimal
timing of valve surgery could improve the prognosis of
patients with left-sided IE.
The optimal timing of valve surgery in patients with IE
still remains unclear. In the surgical treatment of IE, there
is always a dilemma whether to operate early to limit the
risk of emboli and worsening heart failure or to delay
surgery until resolution of the infection to reduce the risk
of operation. Previous studies have compared the clinical
outcomes between patients with and without early opera-
tion. However, the definition of early operation varied
among studies from ‘‘operation during the course of antibi-
otic therapy’’ to ‘‘operation within 7 days after diagnosis of
IE.’’ Revilla and colleagues10 found no significant differ-
ence in mortality between urgent operation before antibiotic
treatment has ended and elective operation at completion of
antibiotic therapy. In addition, Tleyjeh and colleagues11 de-
fined early surgery as the operation within 11 days after the
diagnosis of IE and indicated that longer time to surgery
from 12 to 30 days tended to be associated with better
6-month survival. Contrary to these observations, they operation and conventional treatment groups in the propensity-matched
e shows the survival curve in conventional treatment group. Survivals are
rdiovascular Surgery c Volume 142, Number 4 839
FIGURE 2. Comparison of event-free survival between early operation and conventional treatment groups in the propensity-matched pairs. Green line
shows the event-free survival curve in early operation group, and red line shows the event-free survival curve in conventional treatment group. Survivals
are presented as the mean value  standard error. MACE, Major adverse cardiac event.
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Cohort Study group recently found that early surgery of na-
tive valve IE was associated with an in-hospital survival
benefit compared with medical therapy. They defined early
surgery as the surgical intervention during the initial hospi-
talization for IE.12 In the present study, we defined the early
operation as the surgical intervention within 2 weeks after
the initial diagnosis of IE. Because the patients who under-
went operation within 2 weeks after the diagnosis had better
clinical outcome than patients treated with conventional
strategy, the present study suggests that earlier operation
may further improve long-term outcome in patients with IE.TABLE 4. Cerebral complications and neurologic outcomes among
patients with stroke
Early
operation
(n ¼ 30)
Conventional
treatment
(n ¼ 43)
P
value
Cerebral complications
Cerebral infarction, n (%) 27 (90) 34 (79) .18
Symptomatic, n (%) 14 (47) 27 (63) .17
Silent, n (%) 13 (43) 7 (16) .01
Hemorrhagic, n (%) 3 (10) 9 (21) .18
Cerebral hemorrhage, n (%) 3 (10) 9 (21) .18
Cerebral hemorrhage and infarction,
n (%)
2 (7) 7 (16) .20
Mycotic aneurysm, n (%) 1 (3) 6 (14) .13
Neurologic outcomes
Postoperative cerebral infarction,
n (%)
4 (13) 1 (4)* .22
Postoperative cerebral hemorrhage,
n (%)
5 (17) 1 (4)* .13
Neurologic worsening, n (%) 4 (13) 6 (14) .61
In-hospital death, n (%) 1 (3) 11 (26) .01
*Among patients who underwent late operation.
840 The Journal of Thoracic and Cardiovascular SurgThere may be several rationales for careful indications of
the early operation in the active phase. First, most patients
who require early surgical intervention have many IE-
related complications that may affect prognosis. Previous
studies reported the predictors of death in patients with IE,
including heart failure, embolic events, large vegetations,
and intracardiac abscess.13-16 In our study, patients in the
early operation group were more likely to have heart
failure and large vegetations. These factors can be
possible risks for the early operation. Second, antibiotic
therapy can decrease the burden of microorganisms and
improve the condition of the patients in the acute septic
phase and reduce the operative mortality. Third,
antibiotics therapy can reduce the vegetation size and risk
of embolic events, such as cerebral infarction. On the
other hand, there are also several benefits in early surgical
intervention. The early operation can prevent the
development of heart failure caused by progressive
regurgitation. In addition, removal of the vegetations and
infected fields by the early operation can reduce the risk
of future embolic events and expansion of infection.17 De-
spite these potential benefits of early surgery, Thuny and
colleagues18 observed that early surgical intervention for
IE in the presence of sepsis can elevate the risk of relapsing
IE by placing the prosthetic materials into an infected field.
However, in our study, there were no significant differences
in repeat operations and recurrence of IE between groups. In
view of the relatively low rate of repeat operations and recur-
rence of infection, early surgery in the active phase could be
a rational therapeutic strategy for patients with left-sided IE.
The timing of surgical intervention in patients with cere-
bral complications is particularly controversial. Secondary
neurologic exacerbation may arise after suppression of
coagulation and hypotension during extracorporeal circula-
tion. Previous reports found that cardiac surgery should beery c October 2011
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tions.19,20 On the other hand, Piper and colleagues21 re-
cently reported that cardiac surgery should be performed
within 72 hours of cerebral embolism, when the risk of sec-
ondary cerebral hemorrhage seemed to be low. In addition,
Shang and colleagues22 found that in patients with mitral
valve IE, surgery should not be delayed because of neuro-
logic symptoms or abnormalities on brain imaging with
the exception of large hematomas. The present study found
that the incidence of in-hospital death was significantly
lower in patients with stroke in the early operation group
than those in the conventional treatment group, although
the type of concomitant stroke was different between the
2 groups. On the other hand, the incidence of neurologic
worsening was comparable between the 2 groups. These re-
sults suggest that early operation for patients with cerebral
complications may be an acceptable therapeutic option.
However, further investigations will be required to clarify
the optimal timing of the surgical intervention and identify
which patient is best suited to valve surgery in patients with
cerebral complications.
In the present study, the rate of mitral valve repair among
patients with mitral IE in the early operation group was rel-
atively high (75%), considering that the feasibility of mitral
valve repair in active IE has been reported to vary from 34%
to 78%.23-25 Because it has been reported that the incidence
of reinfection was lower for patients undergoing mitral
valve repair for active mitral IE compared with those
undergoing mitral valve replacement,23 the higher mitral
valve repair rate in our study compared with previous stud-
ies might be associated with the favorable clinical outcomes
in the early operation group.Study Limitations
The major limitations of this study are that the clinical
data in this study were retrospectively reviewed and that
the treatment selection was not based on a prospective ran-
domized assignment. Although the use of propensity analy-
sis to adjust for confounding was intended to minimize
selection bias, it cannot completely control the effect of
confounding. In particular, it is not possible by any study
design to completely remove the selection bias associated
with surgical judgment. Moreover, although we used rigor-
ous statistical methods to adjust for the severity of disease
and host-related factors, there may still be unmeasured con-
founding that could account for the outcomes. In addition,
this study reported findings of a single center, resulting in
limitations to the generalization of the results.CONCLUSIONS
Compared with the conventional treatment, early surgery
in active phase was associated with better long-term out-
comes in patients with left-sided native valve IE. FurtherThe Journal of Thoracic and Carandomized studies with a large study population in multi-
center settings will be required to determine the optimal
timing of surgery in patients with native valve IE.References
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TABLE E1. Baseline characteristics after propensity matching
Early
operation
(n ¼ 57)
Conventional
treatment
(n ¼ 57)
P
value
Background
Age, y  SD 55  18 52  18 .37
Male, n (%) 34 (60) 36 (63) .83
Hypertension, n (%) 11 (19) 10 (18) 1.00
Diabetes, n (%) 10 (18) 10 (18) 1.00
Chronic renal failure, n (%) 7 (12) 9 (16) .77
Valvular disease, n (%) 21 (37) 24 (42) .69
Coronary artery disease, n (%) 2 (4) 2 (4) 1.00
Ejection fraction<50%, n (%) 2 (4) 3 (5) 1.00
Pathogens
Streptococcus sp, n (%) 29 (51) 30 (53) 1.00
Staphylococcus sp, n (%) 8 (14) 14 (25) .21
Vegetation site
Aortic valve, n (%) 29 (51) 28 (49) 1.00
Mitral valve, n (%) 39 (68) 40 (70) 1.00
Both aortic and mitral valves,
n (%)
11 (19) 13 (23) .80
Complication
Heart failure, n (%) 31 (54) 31 (54) 1.00
Valve perforation, n (%) 30 (53) 26 (46) .57
Cardiac abscess, n (%) 9 (16) 10 (18) 1.00
Vegetation size>10 mm, n (%) 32 (56) 37 (65) .33
Cerebral infarction, n (%) 20 (35) 24 (42) .58
Cerebral hemorrhage, n (%) 5 (9) 7 (12) .77
Mycotic aneurysm, n (%) 1 (2) 3 (5) .63
euroSCORE logistic,%  SD 8.3  7 9.0  11 .44
SD, Standard deviation.
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